Within the context of the above discussion, Edison’s valuation of Lepidico, above, is sensitive to at least seven specific factors – three of which are empirical and the balance of which are conceptual. These are considered in turn, below.
The most evident risk to Lepidico from the uncertainty surrounding the coronavirus pandemic are volatile capital markets in the short term and delays in the finalisation of agreements with third parties in the medium term. Otherwise, we do not believe that the coronavirus will have a material impact on long-term demand for lithium or the uptake of electric vehicles in preference to traditional petrol engine vehicles. In the meantime, the company reports that constructive discussions continue with prospective off-take partners for the planned products from the Phase 1 chemical plant and samples continue to be prepared and dispatched for analysis. Essential feasibility study and corporate functions are continuing, non-essential functions have been curtailed and cash resources are estimated to be sufficient to sustain the business into late calendar 2020.
As a part of its acquisition of Desert Lion, Lepidico acquired a convertible note that was originally convertible into Desert Lion equity at a price of C$0.20/share and is now convertible into 108m Lepidico shares at a price of approximately 4 Australian cents at any time prior to 10 December 2020. Our valuation, above, implicitly treats this convertible note as if it were conventional debt. However, in the event that it were to be converted in full, then our valuation of Lepidico falls very fractionally to 7.28 Australian cents per share (cf our ‘base case’ valuation of 7.34c/share).
Edison’s long-term lithium prices are based on an assumed benchmark lithium carbonate price of US$12,000/t, which equates to a lithium hydroxide monohydrate price of US$14,021/t. Variations in our valuation of Lepidico with respect to the lithium hydroxide monohydrate price are as follows:
Exhibit 4: Lepidico valuation sensitivity to lithium hydroxide price
Implied equivalent lithium carbonate price (US$/t) |
5,565 |
6,207 |
6,849 |
7,500 |
8,562 |
10,274 |
12,000 |
13,700 |
15,411 |
Lithium hydroxide price (US$/t) |
6,500 |
7,250 |
8,000 |
8,760 |
10,000 |
12,000 |
14,021 |
16,000 |
18,000 |
Change vs base case (%) |
-53.6 |
-48.3 |
-42.9 |
-37.5 |
-28.7 |
-14.4 |
u/c |
+14.1 |
+28.4 |
Valuation (Australian cents/share) |
2.11 |
2.63 |
3.15 |
3.67 |
4.54 |
5.93 |
7.34 |
8.73 |
10.13 |
Change vs base case (%) |
-71.3 |
-64.2 |
-57.1 |
-50.0 |
-38.1 |
-19.2 |
u/c |
+18.9 |
+38.0 |
Source: Edison Investment Research
Future equity funding price
Edison’s financial model assumes that Lepidico will raise A$68.4m in the relatively near future in order to achieve a future, maximum net debt:equity ratio of 60:40 and that it will raise this equity at a share price of 2.9c. Exhibit 5, below, demonstrates the sensitivity of our valuation to the price at which future equity funding is conducted:
Exhibit 5: Lepidico valuation sensitivity to future equity funding price
Equity funding price (cents/share) |
0.5 |
0.6 |
0.7 |
0.8 |
0.9 |
1.0 |
2.0 |
2.9 |
4.0 |
LPD valuation (cents/share) |
2.67 |
3.06 |
3.42 |
3.75 |
4.05 |
4.33 |
6.31 |
7.34 |
8.16 |
Change vs base case (%) |
-63.6 |
-58.3 |
-53.4 |
-48.9 |
-44.8 |
-41.0 |
-14.0 |
u/c |
+11.2 |
Source: Edison Investment Research.
As a matter of interest, readers should note that the non-diluting price of future equity funding (ie the price at which Edison’s post-funding value is the same as the funding price) is 9.99 cents per share.
In our mining sector report, entitled Gold stars and black holes, published in January 2019, we calculated that the average company enterprise value (EV) for companies at the pre-feasibility stage of development was 9.9% of attributable project NPV. This rose to 30.9% for companies at a bankable stage of development. Taking the non-diluting price of future equity funding of 9.99c to represent project NPV on a per share basis, Lepidico’s share price of 1.0c is in line with the average for companies at PFS stage (albeit Edison has had to vary its financial model to reflect changed circumstances since the original PFS). On completion of a bankable study (scheduled in May) on substantially the same terms as the PFS however, we would expect Lepidico’s shares to re-rate to something close to 30.9% of 9.99c, or approximately 3.1c per share – ie close to our assumed price of future equity funding of 2.9c (see pages 7–9).
In addition to its in-situ resource, our site visit to Karibib also revealed clear evidence of a surface stockpile of broken massive lepidolite ore, being a legacy of former petalite mining at Rubicon, where it was considered waste. To date, this has been excluded from Karibib’s formal mineral resource estimate (Exhibit 1). However, management estimates the size of the stockpile to be in the order of 700kt at a grade of c 0.9% lithium oxide with c 20kt in excess of 1.1% (cf an average grade of 0.40% Li2O at Rubicon – see Exhibit 1). This being the case, we estimate that the stockpile could represent a material circa two years of feed to Lepidico’s Phase 1 L-Max plant, from which c 100–150kt of lepidolite concentrate could be produced.
Lepidico also has access to 69.4kt of slimes at Rubicon, at an elevated grade of 0.95% Li2O, being the flotation tailings related to former petalite mining at Rubicon. While these require mineralogical test-work to be performed before their compatibility with the L-Max process can be determined, they nevertheless represent an additional potential source of material for Lepidico. Utilisation of the slimes would also qualify as tailings disposal/remediation for environmental, social and governance (ESG) purposes.
According to Lepidico’s first optimised production schedule of by-product volumes, the Karibib resource has the ability to support production of c 1,400tpa of rubidium sulphate, equivalent to 1,368tpa of rubidium formate. While the use of rubidium formate as a completion fluid for high pressure, high temperature oil wells is not as developed as that of caesium formate (see our note, Lepidico: Caesing the opportunity, published on 19 November 2019), with chemical and physical properties typically lying in a range between those of caesium and potassium, there seems little reason why it should not develop a function in this role.
While caesium’s crustal abundance of 3ppm is instrumental in conferring upon its formate salt a price in the order of US$37,000–50,000/t (see Exhibit 6, below), we estimate that rubidium’s higher crustal abundance of 90ppm would confer upon its formate salt a price in the region of US$7,158/t. Nevertheless, on this basis, 1,368tpa of rubidium formate at a price of US$7,158/t could potentially generate a very similar (or even greater) revenue to 210tpa of caesium formate at a price of US$37,000/t (see Exhibit 3).
Exhibit 6: Price (US$/t) vs crustal abundance (ppm), selected metals and minerals
|
|
Source: Edison Investment Research
|
Desert Lion’s business plan was based around a concentrator throughput rate of 2.35Mtpa and its water abstraction rates (which Lepidico has inherited) are consequently similarly based upon this rate, which is materially in excess of Lepidico’s initial throughput design rate of 330ktpa, rising to 540ktpa. As such, Lepidico’s right to abstract 207,000m3 of water per annum is sufficient to at least support a doubling of production capacity to 11ktpa of lithium hydroxide monohydrate and potentially more if it applies for additional water rights, either from further water bores close to the mine or by application to NamWater. As such, Lepidico’s business plan at Karibib has expansion potential in addition to duplication potential and the potential for a large-scale Phase 2 plant.
Three other initiatives that have the potential to augment the economics of Lepidico’s mining plan at Karibib include 1) the possibility of steepening the walls of the proposed open pits; 2) mining the footwall mining zone at Helikon, in particular, which has returned grades as high as 3% lithium oxide over 5–6m in exploration drilling; and 3) the potential for gold exploration success.
Finally, Lepidico’s environmental and social impact assessments point to the following benefits at both its mining operation at Karibib and its lepidolite chemical conversion plant in Abu Dhabi:
Karibib lithium mining project
■
Brownfields – redevelopment of the mining operation has been designed within the footprints of former mining activities
■
Sustainable and industry best practice closure plans will rectify mining and processing legacy issues
■
The creation of 85 jobs to benefit local communities, with no relocation requirement
■
The potential to use renewable energy via Power Purchase Agreements with renewable energy providers
■
No tailings storage facility as a result of the co-disposal of benign dry stacked flotation plant tails with mine waste
■
Small scale (and potentially electrically powered) mining fleet
■
Water sourced locally from well bores with >85% of process water recycled
Lepidolite chemical conversion plant
■
Relatively modest power consumption – gas fired electrical power to be supplemented by nuclear (2020 start-up)
■
Heat recovery equipment included in design to reduce gas consumption
■
Low emissions with net carbon intensity of 5–7t CO2 per tonne of lithium hydroxide monohydrate produced for the integrated project after amorphous silica credit
■
SOP and Cs/Rb by-products to provide further carbon credits (to be quantified)
■
Residue product could generate additional carbon credits and result in a zero-waste facility
■
Social benefits – creation of 119 new jobs and low impact as built on existing industrial park
■
Small footprint minimises steel and concrete in construction
Exhibit 7: Financial summary
Accounts: IFRS; year end June; A$000s |
|
|
2015 |
2016 |
2017 |
2018 |
2019 |
2020e |
2021e |
Income statement |
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
9 |
116 |
127 |
171 |
2 |
0 |
0 |
Cost of sales |
|
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Gross profit |
|
|
9 |
116 |
127 |
171 |
2 |
0 |
0 |
SG&A (expenses) |
|
|
(455) |
(617) |
(912) |
(5,284) |
(4,006) |
(7,001) |
(3,146) |
Other income/(expense) |
|
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Exceptionals and adjustments |
|
|
(16) |
(415) |
(878) |
(2,171) |
(1,150) |
(1,331) |
0 |
Depreciation and amortisation |
|
|
(5) |
(6) |
(6) |
(6) |
(8) |
(163) |
(163) |
Reported EBIT |
|
|
(467) |
(923) |
(1,670) |
(7,290) |
(5,162) |
(8,496) |
(3,309) |
Finance income/(expense) |
|
|
(18) |
(5) |
128 |
70 |
57 |
52 |
283 |
Other income/(expense) |
|
|
(559) |
(448) |
(3,815) |
0 |
0 |
0 |
0 |
Exceptionals and adjustments |
|
|
0 |
(888) |
0 |
0 |
0 |
0 |
0 |
Reported PBT |
|
|
(1,044) |
(2,263) |
(5,357) |
(7,220) |
(5,105) |
(8,444) |
(3,027) |
Income tax expense (includes exceptionals) |
|
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Reported net income |
|
|
(1,044) |
(2,263) |
(5,357) |
(7,220) |
(5,105) |
(8,444) |
(3,027) |
Basic average number of shares, m |
|
|
178 |
465 |
1,802 |
2,624 |
3,272 |
5,630 |
6,888 |
Basic EPS (c) |
|
|
(0.0) |
(0.0) |
(0.0) |
(0.0) |
(0.0) |
(0.0) |
(0.0) |
|
|
|
|
|
|
|
|
|
|
Balance sheet |
|
|
|
|
|
|
|
|
|
Property, plant and equipment |
|
|
9 |
4 |
8 |
27 |
18,487 |
24,907 |
144,597 |
Goodwill |
|
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Intangible assets |
|
|
0 |
16,204 |
16,698 |
19,027 |
22,925 |
22,925 |
22,925 |
Other non-current assets |
|
|
1,485 |
715 |
1,620 |
730 |
9,001 |
8,181 |
8,181 |
Total non-current assets |
|
|
1,494 |
16,922 |
18,326 |
19,783 |
50,414 |
56,013 |
175,704 |
Cash and equivalents |
|
|
53 |
650 |
3,307 |
4,860 |
13,660 |
59,802 |
59,802 |
Inventories |
|
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Trade and other receivables |
|
|
4 |
3,886 |
706 |
712 |
1,869 |
0 |
0 |
Other current assets |
|
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Total current assets |
|
|
57 |
4,537 |
4,013 |
5,572 |
15,529 |
59,802 |
59,802 |
Non-current loans and borrowings |
|
|
0 |
0 |
0 |
0 |
3,276 |
3,276 |
125,876 |
Other non-current liabilities |
|
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Total non-current liabilities |
|
|
0 |
0 |
0 |
0 |
3,276 |
3,276 |
125,876 |
Trade and other payables |
|
|
105 |
614 |
1,663 |
804 |
10,940 |
142 |
259 |
Current loans and borrowings |
|
|
115 |
0 |
0 |
0 |
0 |
0 |
0 |
Other current liabilities |
|
|
40 |
33 |
46 |
51 |
86 |
86 |
86 |
Total current liabilities |
|
|
260 |
647 |
1,709 |
856 |
11,026 |
227 |
344 |
Equity attributable to company |
|
|
1,292 |
20,812 |
20,630 |
24,500 |
53,252 |
113,922 |
110,895 |
Non-controlling interest |
|
|
0 |
0 |
0 |
0 |
(1,610) |
(1,610) |
(1,610) |
|
|
|
|
|
|
|
|
|
|
Cash flow statement |
|
|
|
|
|
|
|
|
|
Profit for the year |
|
|
(1,044) |
(2,263) |
(5,357) |
(7,220) |
(5,105) |
(8,444) |
(3,027) |
Taxation expenses |
|
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Depreciation and amortisation |
|
|
5 |
6 |
6 |
6 |
8 |
163 |
163 |
Share based payments |
|
|
450 |
40 |
1,736 |
2,138 |
520 |
511 |
0 |
Other adjustments |
|
|
(451) |
1,036 |
(162) |
2,066 |
664 |
1,641 |
0 |
Movements in working capital |
|
|
(10) |
132 |
133 |
(28) |
410 |
(8,930) |
117 |
Interest paid / received |
|
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Income taxes paid |
|
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Cash from operations (CFO) |
|
|
(1,050) |
(1,049) |
(3,644) |
(3,038) |
(3,504) |
(15,059) |
(2,747) |
Capex |
|
|
(9) |
(63) |
(861) |
(3,057) |
(6,251) |
(7,403) |
(119,854) |
Acquisitions & disposals net |
|
|
0 |
32 |
122 |
110 |
0 |
0 |
0 |
Other investing activities |
|
|
(563) |
(80) |
0 |
0 |
0 |
0 |
0 |
Cash used in investing activities (CFIA) |
|
|
(572) |
(111) |
(739) |
(2,947) |
(6,251) |
(7,403) |
(119,854) |
Net proceeds from issue of shares |
|
|
1,505 |
1,872 |
7,040 |
7,555 |
18,462 |
68,603 |
0 |
Movements in debt |
|
|
100 |
(115) |
0 |
0 |
0 |
0 |
122,600 |
Other financing activities |
|
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Cash from financing activities (CFF) |
|
|
1,605 |
1,757 |
7,040 |
7,555 |
18,462 |
68,603 |
122,600 |
Increase/(decrease) in cash and equivalents |
|
|
(18) |
597 |
2,657 |
1,570 |
8,707 |
46,142 |
0 |
Currency translation differences and other |
|
|
0 |
0 |
0 |
(17) |
93 |
0 |
0 |
Cash and equivalents at end of period |
|
|
53 |
650 |
3,307 |
4,860 |
13,660 |
59,802 |
59,802 |
Net (debt)/cash |
|
|
(61) |
650 |
3,307 |
4,860 |
10,385 |
56,526 |
(66,074) |
Movement in net (debt)/cash over period |
|
|
(61) |
711 |
2,657 |
1,553 |
5,525 |
46,142 |
(122,600) |
Source: Company sources, Edison Investment Research. Note: FY19 balance sheet is Lepidico’s stated balance sheet consolidated with Edison’s estimate of Desert Lion’s balance sheet as at 30 June 2019, converted into Australian dollars.
General disclaimer and copyright This report has been commissioned by Lepidico and prepared and issued by Edison, in consideration of a fee payable by Lepidico. Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services. Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note. No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors. Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest. Copyright: Copyright 2020 Edison Investment Research Limited (Edison). All rights reserved FTSE International Limited (“FTSE”) © FTSE 2020. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.
Australia Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument. New Zealand The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.
United Kingdom This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document. This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.
United States Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. |
Frankfurt +49 (0)69 78 8076 960 Schumannstrasse 34b 60325 Frankfurt Germany |
London +44 (0)20 3077 5700 280 High Holborn London, WC1V 7EE United Kingdom |
New York +1 646 653 7026 1,185 Avenue of the Americas 3rd Floor, New York, NY 10036 United States of America |
Sydney +61 (0)2 8249 8342 Level 4, Office 1205 95 Pitt Street, Sydney NSW 2000, Australia |
Frankfurt +49 (0)69 78 8076 960 Schumannstrasse 34b 60325 Frankfurt Germany |
London +44 (0)20 3077 5700 280 High Holborn London, WC1V 7EE United Kingdom |
New York +1 646 653 7026 1,185 Avenue of the Americas 3rd Floor, New York, NY 10036 United States of America |
Sydney +61 (0)2 8249 8342 Level 4, Office 1205 95 Pitt Street, Sydney NSW 2000, Australia |
|
General disclaimer and copyright This report has been commissioned by Lepidico and prepared and issued by Edison, in consideration of a fee payable by Lepidico. Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services. Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note. No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors. Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest. Copyright: Copyright 2020 Edison Investment Research Limited (Edison). All rights reserved FTSE International Limited (“FTSE”) © FTSE 2020. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.
Australia Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument. New Zealand The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.
United Kingdom This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document. This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.
United States Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. |
Frankfurt +49 (0)69 78 8076 960 Schumannstrasse 34b 60325 Frankfurt Germany |
London +44 (0)20 3077 5700 280 High Holborn London, WC1V 7EE United Kingdom |
New York +1 646 653 7026 1,185 Avenue of the Americas 3rd Floor, New York, NY 10036 United States of America |
Sydney +61 (0)2 8249 8342 Level 4, Office 1205 95 Pitt Street, Sydney NSW 2000, Australia |
Frankfurt +49 (0)69 78 8076 960 Schumannstrasse 34b 60325 Frankfurt Germany |
London +44 (0)20 3077 5700 280 High Holborn London, WC1V 7EE United Kingdom |
New York +1 646 653 7026 1,185 Avenue of the Americas 3rd Floor, New York, NY 10036 United States of America |
Sydney +61 (0)2 8249 8342 Level 4, Office 1205 95 Pitt Street, Sydney NSW 2000, Australia |
|